Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2017 · 10-Q
Revenue$405.86M$405.86M+4.0% vs Q1 2016 Net Income$29.84M$29.84M+20.1% vs Q1 2016 EPS Diluted$1.78$1.78+22.8% vs Q1 2016 Operating Income$41,454,000−6.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$59,766,000N/M Margins · derivedOperating margin10.2%−1.2 pt vs Q1 2016
Net margin7.4%+1.0 pt vs Q1 2016
ended Mar 31, 2017 · filed Apr 28, 2017 · 28 d after period end